Refine
Has Fulltext
- yes (15)
Is part of the Bibliography
- yes (15)
Year of publication
Document Type
- Journal article (15)
Language
- English (15)
Keywords
- cancer (2)
- colorectal cancer (2)
- gastric cancer (2)
- gemcitabine (2)
- oral anticancer drugs (2)
- survival (2)
- 5-Fluorouracil (1)
- BCOR (1)
- BCORL1 (1)
- CA19-9 (1)
- CD4(+) (1)
- FOLFIRI (1)
- FOLFOX (1)
- Improved survival (1)
- Interleukin-2 (1)
- MTB (1)
- NGS (1)
- NK cells (1)
- POU6F2-AS2 (1)
- Rectal cancer (1)
- TME (1)
- acute myeloid leukemia (1)
- acute myeloid-leukemia (1)
- adenocarcinoma of the ampulla of Vater (1)
- adjuvant (1)
- adoptive transfer (1)
- biophosphonate (1)
- cancer care (1)
- cancer treatment (1)
- capecitabine (1)
- cfRNA (1)
- chemotherapy (1)
- cholestasis (1)
- complication (1)
- comprehensive management (1)
- curative resection (1)
- ddPCR (1)
- early detection (1)
- fear of progression (1)
- folinic acid (1)
- gammadelta T cells (1)
- haploidentical γδ T lymphocytes (1)
- hepatic resection (1)
- immunosurveillance (1)
- immunotherapy (1)
- in vivo cell expansion (1)
- infusion (1)
- innate immunity (1)
- intestinal-type adenocarcinoma (1)
- irinotecan (1)
- liquid biopsy (1)
- locally advanced disease (1)
- loss-of-function (1)
- lung resection (1)
- metachronous (1)
- metastasis (1)
- multimodal (1)
- nab-paclitaxel (1)
- nanoparticle albumin-bound paclitaxel (1)
- neoadjuvant (1)
- neoadjuvant chemotherapy (1)
- outcomes research (1)
- outreach (1)
- oxaliplatin (1)
- pancreatic adenocarcinoma (PDAC) (1)
- pancreatic cancer (1)
- pancreatic head cancer (1)
- pancreatobiliary type (1)
- patient access (1)
- patient-doctor-relationship (1)
- perioperative chemotherapy (1)
- peritoneal carcinomatosis (1)
- precision oncology (1)
- real world data (1)
- recurrence survival (1)
- risk factor (1)
- risk factors (1)
- risk stratification (1)
- screening for distress (1)
- stimulation (1)
- surgical oncology (1)
- surgical resection (1)
Institute
- Medizinische Klinik und Poliklinik II (12)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (7)
- Comprehensive Cancer Center Mainfranken (4)
- Abteilung für Molekulare Innere Medizin (in der Medizinischen Klinik und Poliklinik II) (2)
- Theodor-Boveri-Institut für Biowissenschaften (2)
- Institut für Klinische Biochemie und Pathobiochemie (1)
- Institut für Virologie und Immunbiologie (1)
- Klinik und Poliklinik für Nuklearmedizin (1)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (1)
- Klinik und Poliklinik für Strahlentherapie (1)
EU-Project number / Contract (GA) number
- 641458 (1)
Butyrophilin (BTN)–3A and BTN2A1 molecules control the activation of human Vγ9Vδ2 T cells during T cell receptor (TCR)-mediated sensing of phosphoantigens (PAg) derived from microbes and tumors. However, the molecular rules governing PAg sensing remain largely unknown. Here, we establish three mechanistic principles of PAg-mediated γδ T cell activation. First, in humans, following PAg binding to the intracellular BTN3A1-B30.2 domain, Vγ9Vδ2 TCR triggering involves the extracellular V-domain of BTN3A2/BTN3A3. Moreover, the localization of both protein domains on different chains of the BTN3A homo-or heteromers is essential for efficient PAg-mediated activation. Second, the formation of BTN3A homo-or heteromers, which differ in intracellular trafficking and conformation, is controlled by molecular interactions between the juxtamembrane regions of the BTN3A chains. Finally, the ability of PAg not simply to bind BTN3A-B30.2, but to promote its subsequent interaction with the BTN2A1-B30.2 domain, is essential for T-cell activation. Defining these determinants of cooperation and the division of labor in BTN proteins improves our understanding of PAg sensing and elucidates a mode of action that may apply to other BTN family members.